Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

High retinol intake may worsen hair loss in alopecia areata.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

Baricitinib treatment for severe alopecia areata shows significant improvement by 52 weeks, especially in very severe cases.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Alopecia areata treatments often don't lead to lasting improvement.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Alopecia areata patients have lower vitamin D levels than healthy individuals.

Wearing wigs or hairpieces improves self-esteem, adaptability, and competence in women with alopecia areata.